Organization
U.S. District Court for the District of New Jersey
Federal trial court for New Jersey.
- Pain22 scenes
- Forever20 scenes
- The Settlements20 scenes
- How are U.S. District Court for the District of New Jersey and … connected?
Connections 5
convicted
- Purdue Pharma 24 Nov 2020 conspiracy to defraud the United States and to violate the Food, Drug, and Cosmetic Act; conspiracy to violate the Anti-Kickback Statute Primary record 1
settled with
involved in
- J&J talc settlement proposal, July 2026 on 22 July 2026 a magistrate judge doubted plaintiffs could prove specific causation and ordered them to respond by 19 November Scholarship & press 3
- Purdue Pharma guilty plea (2020) court that took the plea Primary record 1
located in
Timeline 2 dates
- 22 May 2008 De Beers settled with U.S. District Court for the District of New Jersey
- 24 Nov 2020 Purdue Pharma convicted by U.S. District Court for the District of New Jersey
Proof 3 sources
-
Opioid Manufacturer Purdue Pharma Pleads Guilty to Fraud and Kickback Conspiracies, U.S. Department of Justice, 24 Nov 2020.
Primary record
Archived copy
Purdue pleaded guilty to an information charging it with three felony offenses: one count of dual-object conspiracy to defraud the United States and to violate the Food, Drug, and Cosmetic Act, and two counts of conspiracy to violate the Federal Anti-Kickback Statute.
Purdue admitted that from May 2007 through at least March 2017, it conspired to defraud the United States by impeding the lawful function of the Drug Enforcement Administration (DEA).
Purdue made payments to Practice Fusion Inc., an electronic health records company
including a criminal fine of $3.544 billion and an additional $2 billion in criminal forfeiture.
Opioid manufacturer Purdue Pharma LP (Purdue) pleaded guilty today in federal court in Newark, New Jersey, to conspiracies to defraud the United States and violate the anti-kickback statute.
-
Sullivan v. DB Investments, Inc., 667 F.3d 273 (3d Cir. 2011) (en banc), U.S. Court of Appeals for the Third Circuit, 20 Dec 2011.
Primary record
The settlement provided for a fund of $295 million to be distributed to both the direct and indirect purchasers: the direct purchasers were to receive $22.5 million of the fund,
-
Federal Judge Casts Doubt on 69,000 Cases Alleging J&J Talc Caused Cancer (Reuters, via Insurance Journal), Reuters, via Insurance Journal, 23 Jul 2026.
Scholarship & press
The judge ordered plaintiffs to respond by November 19, and to explain why their case should not be dismissed over the failure to provide an admissible expert opinion that J&J talc caused their specific cancer.
U.S. Magistrate Judge Rukhsanah Singh in Trenton, New Jersey, said that recent testimony by two of the plaintiffs’ experts raised doubts about whether any plaintiffs can provide evidence admissible in court “that talcum powder use specifically caused her ovarian cancer.”
Page history 1 change
- Add 55 stories, each checked against its sources96e92fe6
Something wrong or missing? Tell us, with a source, or edit this page.